ASBMR Webinar on New Directions in Therapeutics of Rare Bone Diseases
Date: December 11, 2013
Catch the latest ASBMR webinar – New Directions in Therapeutics of Rare Bone Diseases: X-Linked Hypophosphatemia (XLH) and Hypophosphatasia (HPP) – on Tuesday, December 17. Erik Imel, M.D., and Michael P. Whyte, M.D., will present the webinar, which will prove updates on new clinical strategies for these two rare bone diseases. Learn more and register today.
Supported by an education donation provided by Alexion Pharmaceuticals.